Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.59 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.52 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | GSK3B | P49841 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9641208 | 0.92 | CTBP2 (0.57) | CTBP2SAE1UBA2HTTFFAR1 | |
| SCHEMBL9190571 | 0.90 | NSD2 (0.55) | CTBP2LOXL2CYP2A6SAE1UBA2 | |
| SCHEMBL13483247 | 0.90 | CTBP2 (0.54) | CTBP2LOXL2CYP2A6SAE1UBA2 | |
| SCHEMBL16887632 | 0.88 | CYP2A6 (0.55) | CTBP2LOXL2CYP2A6SAE1UBA2 | |
| SCHEMBL12374116 | 0.88 | CTBP2 (0.53) | CTBP2LOXL2CYP2A6SAE1UBA2 | |
| SCHEMBL28162772 | 0.87 | CTBP2 (0.49) | CTBP2LOXL2CYP2A6SAE1UBA2 | |
| SCHEMBL10275551 | 0.86 | CTBP2 (0.56) | CTBP2LOXL2CYP2A6SAE1UBA2 | |
| SCHEMBL19798045 | 0.86 | NSD2 (0.51) | CTBP2SAE1UBA2HTTFFAR1 | |
| SCHEMBL28399752 | 0.85 | CTBP2 (0.50) | CTBP2LOXL2CYP2A6SAE1UBA2 | |
| SCHEMBL335492 | 0.84 | CTBP2 (0.62) | CTBP2LOXL2CYP2A6SAE1UBA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | CANON KABUSHIKI KAISHA (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20210139417-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2021-05-13 | — | — | US | disclosed |
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | CANON KABUSHIKI KAISHA (JP) | 2020-02-13 | — | — | US | disclosed |
| US-9472766-B2 | Fused polycyclic compound and organic light emitting element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9472766-B2 | Fused polycyclic compound and organic light emitting element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2016-02-04 | — | — | US | disclosed |
| EP-0842943-B1 | 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists | HOECHST AG (DE) | 2003-02-26 | — | — | EP | disclosed |
| EP-0771196-B1 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 1999-12-08 | — | — | EP | disclosed |
| EP-0842943-A2 | 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-05-20 | — | — | EP | disclosed |
| US-5717109-A | CARBOXYCYCLOPROPYL GLYCINE DERIVATIVES; USEFUL FOR TREATMENT OF ACUTE OR CHRONIC NEURODEGENERATIVE CONDITIONS, AND AS ANTIPSYCHOTIC, ANTICONVULSANT, ANALGESIC, ANXIOLYTIC, ANTIDEPRESSANT AND ANTI-EMETIC AGENTS | ELI LILLY AND COMPANY (US) | 1998-02-10 | — | — | US | disclosed |
| EP-0771196-A4 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 1997-09-03 | — | — | EP | disclosed |
| EP-0771196-A1 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-05-07 | — | — | EP | disclosed |
| WO-1996007405-A1 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1996-03-14 | — | — | WO | disclosed |
| US-5200561-A | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-04-06 | — | — | US | disclosed |
| US-4732907-A | Antiprotozoal diamidines and bis-imidazoline | PFIZER INC. (US) | 1988-03-22 | — | — | US | disclosed |
| US-4624958-A | Antiprotozoal 1,4-di(p-amidinophenyl)imidazoles | PFIZER INC. (US) | 1986-11-25 | — | — | US | disclosed |
| US-4546113-A | Antiprotozoal diamidines | PFIZER INC. (US) | 1985-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | NR2E3, PUF60, CRY2 | CTBP2 1055/4885LOXL2 2630/4885CYP2A6 1804/4885 |
| US-20200048171-A1 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT | OCIAD1, L1CAM, SPIN4 | CTBP2 3673/4885LOXL2 97/4885CYP2A6 2624/4885 |
| US-20210139417-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CYP1A1, POU2F1, NFE2L2 | CTBP2 1483/4885LOXL2 592/4885CYP2A6 127/4885 |
| US-11370733-B2 | Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object | OCIAD1, L1CAM, SPIN4 | CTBP2 3673/4885LOXL2 97/4885CYP2A6 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.